Transforming Growth Factor-β Blockade Down-Regulates the Renin-Angiotensin System and Modifies Cardiac Remodeling after Myocardial Infarction
- 24 July 2008
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 149 (11) , 5828-5834
Abstract
After myocardial infarction (MI), the heart may undergo progressive ventricular remodeling, resulting in a deterioration of cardiac function. TGF-β is a key cytokine that both initiates and terminates tissue repair, and its sustained production underlies the development of tissue fibrosis, particularly after MI. We investigated the effects of a novel orally active specific inhibitor of the TGF-β receptor 1 (SD-208) in an experimental model of MI. Mice underwent ligation of the left coronary artery to induce MI and were subsequently treated for 30 d after infarction with either SD-208 or a vehicle control. Blockade of TGF-β signaling reduced mean arterial pressure in all groups. SD-208 treatment after MI resulted in a trend for reduced ventricular and renal gene expression of TGF-β-activated kinase-1 (a downstream modulator of TGF-β signaling) and a significant decrease in collagen 1, in association with a marked decrease in cardiac mass. Post-MI SD-208 treatment significantly reduced circulating levels of plasma renin activity as well as down-regulating the components of the cardiac and renal renin-angiotensin system (angiotensinogen, angiotensin converting enzyme, and angiotensin II type I receptor). Our findings indicate that blockade of the TGF-β signaling pathway results in significant amelioration of deleterious cardiac remodeling after infarction.Keywords
This publication has 38 references indexed in Scilit:
- Role of the TGF-β/Alk5 Signaling Pathway in Monocrotaline-induced Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Role of transforming growth factor-β superfamily signaling pathways in human diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2008
- TGF-β1 stimulates human AT1receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathwaysAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- The TGFβ superfamily in cardiovascular biologyCardiovascular Research, 2007
- The role of TGF-β signaling in myocardial infarction and cardiac remodelingCardiovascular Research, 2007
- Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-β in carotid artery of atherosclerotic rabbitsAtherosclerosis, 2003
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- In Vivo Effect of TGF-β1Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Outpatient Screening Tests for Primary AldosteronismAustralian and New Zealand Journal of Medicine, 1976